These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27901086)
1. Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway. Zhang E; Yin S; Song X; Fan L; Hu H Sci Rep; 2016 Nov; 6():38138. PubMed ID: 27901086 [TBL] [Abstract][Full Text] [Related]
2. Involvement of activation of PLIN5-Sirt1 axis in protective effect of glycycoumarin on hepatic lipotoxicity. Zhang E; Yin S; Zhao C; Fan L; Hu H Biochem Biophys Res Commun; 2020 Jul; 528(1):7-13. PubMed ID: 32448510 [TBL] [Abstract][Full Text] [Related]
4. Saturated free fatty acid sodium palmitate-induced lipoapoptosis by targeting glycogen synthase kinase-3β activation in human liver cells. Cao J; Feng XX; Yao L; Ning B; Yang ZX; Fang DL; Shen W Dig Dis Sci; 2014 Feb; 59(2):346-57. PubMed ID: 24132507 [TBL] [Abstract][Full Text] [Related]
5. Glycycoumarin ameliorates alcohol-induced hepatotoxicity via activation of Nrf2 and autophagy. Song X; Yin S; Huo Y; Liang M; Fan L; Ye M; Hu H Free Radic Biol Med; 2015 Dec; 89():135-46. PubMed ID: 26169726 [TBL] [Abstract][Full Text] [Related]
7. Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway. Chen X; Bian M; Zhang C; Kai J; Yao Z; Jin H; Lu C; Shao J; Chen A; Zhang F; Zheng S Biomed Pharmacother; 2018 Jan; 97():975-984. PubMed ID: 29136776 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis. Takaki H; Akazawa Y; Kido Y; Morishita M; Honda T; Shibata H; Miuma S; Miyaaki H; Taura N; Kondo H; Nakao K Med Sci Monit; 2017 Sep; 23():4526-4532. PubMed ID: 28931802 [TBL] [Abstract][Full Text] [Related]
9. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways. Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220 [TBL] [Abstract][Full Text] [Related]
11. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis. Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645 [TBL] [Abstract][Full Text] [Related]
12. Ginkgolide A ameliorates non-alcoholic fatty liver diseases on high fat diet mice. Jeong HS; Kim KH; Lee IS; Park JY; Kim Y; Kim KS; Jang HJ Biomed Pharmacother; 2017 Apr; 88():625-634. PubMed ID: 28142119 [TBL] [Abstract][Full Text] [Related]
13. Scopoletin and umbelliferone protect hepatocytes against palmitate- and bile acid-induced cell death by reducing endoplasmic reticulum stress and oxidative stress. Wu Z; Geng Y; Buist-Homan M; Moshage H Toxicol Appl Pharmacol; 2022 Feb; 436():115858. PubMed ID: 34979142 [TBL] [Abstract][Full Text] [Related]
14. C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress. Jung TW; Hong HC; Hwang HJ; Yoo HJ; Baik SH; Choi KM Mol Cell Endocrinol; 2015 Dec; 417():131-40. PubMed ID: 26419929 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of glycycoumarin on liver diseases. Zhang E; Yin S; Zhao S; Zhao C; Yan M; Fan L; Hu H Phytother Res; 2020 Jun; 34(6):1191-1197. PubMed ID: 31840883 [TBL] [Abstract][Full Text] [Related]
16. Glycycoumarin protects mice against acetaminophen-induced liver injury predominantly via activating sustained autophagy. Yan M; Ye L; Yin S; Lu X; Liu X; Lu S; Cui J; Fan L; Kaplowitz N; Hu H Br J Pharmacol; 2018 Oct; 175(19):3747-3757. PubMed ID: 30024038 [TBL] [Abstract][Full Text] [Related]
17. Protein Phosphatase 4 Promotes Hepatocyte Lipoapoptosis by Regulating RAC1/MLK3/JNK Pathway. Huang X; Yang G; Zhao L; Yuan H; Chen H; Shen T; Tang W; Man Y; Ma J; Ma Y; Dou L; Li J Oxid Med Cell Longev; 2021; 2021():5550498. PubMed ID: 34221233 [TBL] [Abstract][Full Text] [Related]
18. Non-Alcoholic Fatty Liver Disease. Engin A Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211 [TBL] [Abstract][Full Text] [Related]